Newsroom
Latest news and features
LATEST NEWS
NEWS RELEASE FROM HHS.GOV: HHS, DOD engage Quantum Leap Healthcare Collaborative in search for effective treatments for the sickest COVID-19 patients
15 December 2020
LATEST NEWS
News Release from HHS.GOV: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Moderna
11 December 2020
NEWS
BARDA and Chembio Diagnostics collaborate on two rapid point-of-care diagnostic tests to both detect antigens for COVID-19 and detect and differentiate Influenza from COVID-19.
03 December 2020
NEWS
BARDA DRIVe seeking interested applicants for the Early Notification to Act, Control, and Treat (ENACT) program
02 December 2020
NEWS
News release from HHS.gov: Trump Administration purchases additional doses of Lilly therapeutic to treat patients with mild to moderate COVID-19
02 December 2020
NEWS
BARDA is partnering with Chrysalis BioTherapeutics to continue development of TP508 as a nuclear countermeasure
30 November 2020
NEWS
BARDA partners with Siemens Healthineers to expedite development of a high-throughput, automated antigen test for COVID-19
24 November 2020
NEWS
News release from HHS.gov: HHS Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests
23 November 2020
NEWS
BARDA expands partnership with DiaSorin Inc to develop an enhanced IgG assay for determining COVID-19 patient exposure and immune status
16 November 2020
NEWS
BARDA seeks nonprofit partner for BARDA Ventures: Catalyzing the 21st Century Cures Act and launching a new way to do business with HHS
10 November 2020
NEWS
BARDA and JPEO-CBRND help Humanigen evaluate drug to potentially prevent or treat cytokine storm caused by COVID-19
06 November 2020
NEWS
BARDA and Mesa Biotech collaborate on rapid diagnostics to distinguish coronavirus from influenza infections
06 November 2020
NEWS
News release from HHS.gov: HHS and DOD announce $12.7 million contract with InBios International to boost U.S. production of rapid COVID-19 tests
02 November 2020
NEWS
News release from HHS.gov: HHS and DOD Announce $119 Million Contract to Hologic to Better Meet the Demand of COVID-19 Testing
02 November 2020
NEWS
HHS, BARDA partner with Hologic to expedite development of a high-throughput, automated multiplex SARS-CoV-2/Flu assay
29 October 2020
NEWS
BARDA seeks abstract submissions for medical countermeasure development through the DRIVe ReDIRECT Program
28 October 2020
NEWS
HHS, DOD Collaborate on Plans to Purchase Lilly Investigational Therapeutic to Treat COVID-19
28 October 2020
NEWS
BARDA and Beckman Coulter partner to aid in rapid detection of MIS-C, a pediatric complication of SARS-CoV-2 infection
15 October 2020
NEWS
News Release from HHS.gov: Trump Administration expands manufacturing capacity with Cytiva for components of COVID-19 vaccines
13 October 2020
LATEST PUBLICATIONS
National Action Plan for Combating Antibiotic-Resistant Bacteria 2020-2025
09 October 2020
NEWS
Trump Administration expands collaboration with AstraZeneca to develop and manufacture an investigational monoclonal antibody to prevent COVID-19
09 October 2020
NEWS
BARDA and Current Health partner on remote monitoring to predict likelihood of hospitalization and need for ICU-level support in COVID-19 patients
07 October 2020
NEWS
BARDA and DOD JPEO-CBRND Collaborate with Cepheid on Single, Rapid Diagnostic Test to Detect COVID-19, Influenza and RSV
07 October 2020
NEWS
BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin
05 October 2020
NEWS
Two novel investigational drugs targeting antibiotic-resistant infections move into advanced development with HHS support
30 September 2020
NEWS
BARDA partners with Invirsa to develop a treatment for ocular conditions associated with DNA damage, including sulfur mustard injury
29 September 2020
NEWS
BARDA awards additional funds to Basilea for next steps in antibiotic development to treat bloodstream infections caused by Staphylococcus aureus bacteria
28 September 2020
NEWS
BARDA and Luminex Corporation partner to expedite development of COVID-19 diagnostic test
24 September 2020
NEWS
BARDA and Luminex Corporation enter into a public-private partnership to develop an advanced serology test for use during the COVID-19 pandemic
23 September 2020
NEWS
BARDA Partners with University of Pennsylvania Researchers to Develop a Lung-on-a-Chip for Discovery of Treatments for Chlorine Exposure
21 September 2020
NEWS
BARDA expanded partnership with Ortho Clinical Diagnostics to develop high-throughput, automated COVID-19 antigen and further advancements to antibody tests
18 September 2020
NEWS
BARDA and JPEO-CBRND partner with Ology Bioservices to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed
17 September 2020
NEWS
BARDA collaborates with NOWDiagnostics, Inc. to develop a rapid, point-of-care (POC) and over-the-counter (OTC), in vitro diagnostic test to detect antibodies against SARS-CoV-2
31 August 2020
NEWS
BARDA establishes four new partnerships to explore innovative vaccine delivery technologies
26 August 2020
NEWS
Trump Administration collaborates with Moderna to produce 100 million doses of COVID-19 investigational vaccine
11 August 2020
NEWS
BARDA and JPEO-CBRND partner with Grand River Aseptic Manufacturing to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed
06 August 2020
NEWS
HHS, DOD collaborate with Johnson & Johnson to produce millions of COVID-19 investigational vaccine doses
05 August 2020
NEWS
HHS, DOD partner with Sanofi and GSK on commercial-scale manufacturing demonstration project to produce millions of COVID-19 investigational vaccine doses
31 July 2020
NEWS
BARDA continues to partner with Moderna for the first Phase 3 clinical trial of a COVID-19 vaccine to start in the United States
28 July 2020
NEWS
HHS reserves and rapidly expands manufacturing capacity for COVID-19 vaccines at Texas Center for Innovation in Advanced Development and Manufacturing
27 July 2020
NEWS
BARDA and JPEO-CBRND form partnership with Smiths Medical to expand domestic manufacturing capacity for safety needles and syringes
15 July 2020
NEWS
BARDA and JPEO-CBRND work with Retractable Technologies, Inc. to expand manufacturing of needles and syringes in the US
09 July 2020
NEWS
BARDA and JPEO-CBRND establish partnership with Becton Dickinson to expand domestic manufacturing capacity for needles and syringes
09 July 2020
NEWS
BARDA and DoD work with SiO2 Materials Science to increase domestic manufacturing of vials
07 July 2020
NEWS
HHS, DOD collaborate with Novavax to produce millions of COVID-19 investigational vaccine doses in commercial-scale manufacturing demonstration project
07 July 2020
NEWS
HHS, DOD collaborate with Regeneron on large-scale manufacturing demonstration project of COVID-19 investigational therapeutic treatmen
07 July 2020
NEWS
BARDA partners with Chembio Diagnostics, Inc. to develop a point-of-care in vitro diagnostic test for the detection of SARS-CoV-2 in respiratory specimens
06 July 2020
NEWS
BARDA and Sonica Health expand partnership to develop wearable patch as an early monitoring platform for COVID-19 infection
01 July 2020
NEWS
BARDA partners with Colorado State University’s Infectious Disease Research Center (IDRC) to further develop the SolaVAXTM platform to address COVID-19
25 June 2020
NEWS
BARDA Teams Up with DoD’s JPEO-CBRN and Corning Incorporated to Expand Production of Corning’s Valor ® Glass Vials
19 June 2020
NEWS
BARDA & Empatica forge new partnership to develop an early monitoring platform to identify COVID-19 infection
19 June 2020
NEWS
BARDA supports development of two automated antibody tests for COVID-19 by Ortho Clinical Diagnostics
17 June 2020
NEWS
BARDA and Immunexpress Inc. expand partnership to evaluate a sepsis host-based laboratory diagnostic to triage COVID-19 patients
16 June 2020
NEWS
BARDA DRIVe and Sepsis Alliance to provide educational content on COVID-19 and Sepsis
11 June 2020
NEWS
BARDA, Snapdragon Chemistry Inc., demonstrate deployable domestic manufacturing technology for COVID-19 vaccine component
11 June 2020
NEWS
BARDA, Chembio Diagnostics Partnership Results in FDA-Cleared Diagnostic Test for Zika
10 June 2020
NEWS
BARDA engages Moderna to expand domestic manufacturing of the Moderna SARS-CoV-2 vaccine (mRNA-1273) to protect against COVID-19
05 June 2020
NEWS
BARDA announces partnership with Siemens Healthineers to develop automated total antibody test for COVID-19
02 June 2020
NEWS
BARDA and Genentech expand partnership to begin Phase 2 clinical trial to evaluate investigational treatments for COVID-19 patients
01 June 2020
NEWS
HHS Adds $628 Million to Contract with Emergent BioSolutions to Secure Manufacturing Capacity for Operation Warp Speed
01 June 2020
NEWS
BARDA partners with Merck and IAVI to accelerate development of a vaccine to prevent COVID-19
26 May 2020
NEWS
Trump Administration’s Operation Warp Speed accelerates AstraZeneca COVID-19 vaccine to be available beginning in October
21 May 2020
NEWS
BARDA and VitalConnect partner to monitor nursing home and COVID-19 patients for early indication of patient deterioration
20 May 2020
NEWS
HHS, industry partners expand U.S.-based pharmaceutical manufacturing for COVID-19 response
19 May 2020
NEWS
BARDA announces expanded partnership with Beckman Coulter to assess digital sepsis prediction solution for COVID-19 patients
15 May 2020
NEWS
BARDA supports development of AI-based handheld ultrasound to triage trauma or lung injuries and disease diagnosis, including COVID-19
08 May 2020
NEWS
BARDA engages in a collaboration to support Mayo Clinic Expanded Access Program for use of convalescent plasma to hospitalized patients with COVID-19
04 May 2020
NEWS
BARDA expands partnership with Hologic for development of a second high-throughput molecular assay for SARS-CoV-2
01 May 2020
NEWS
BARDA expands collaboration with Cerus Corporation to evaluate the INTERCEPT Blood System against SARS-CoV-2
28 April 2020
NEWS
BARDA and InBios International, Inc. partner to expedite development for serological tests to identify asymptomatic or recovered cases of COVID-19
27 April 2020
NEWS
BARDA and America’s Blood Centers partner to support and coordinate collection and distribution of convalescent plasma units for COVID-19 patients’ therapeutic use
27 April 2020
NEWS
BARDA announces partnership expansion with Cytovale, Inc. for continued development of Cytovale’s rapid diagnostic system for sepsis as part of COVID-19 pandemic response
23 April 2020
LATEST PUBLICATIONS
Assistant Secretary for Preparedness and Response (ASPR) Strategic Plan for 2020-2023
20 April 2020
NEWS
BARDA and Tangen Biosciences, Inc. entered into a public-private partnership to develop a rapid diagnostic test for SARS-CoV-2
20 April 2020
NEWS
BARDA supports Hememics Biotechnologies, Inc to develop a rapid antigen and antibody diagnostic to identify current or past SARS-CoV-2 infections in 60 seconds
16 April 2020
NEWS
BARDA and American Red Cross collaborate on convalescent plasma for therapeutic use in COVID-19 infected patients
15 April 2020
NEWS
BARDA and Vela Diagnostics USA, Inc. entered into a public-private partnership to develop a rapid diagnostic test for the COVID-19 pandemic
14 April 2020
NEWS
HHS/BARDA supports DiaSorin, Inc to develop a fully automated serology test to detect novel coronavirus infections
13 April 2020
NEWS
HHS supports Nanomix, Inc to develop a rapid mobile diagnostic test to detect presence of current or past COVID-19 infection in patients
08 April 2020
NEWS
HHS, Department of Defense, and Grifols Collaborate to Develop Plasma-based Treatment for COVID-19
07 April 2020
MEETINGS
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop 2016
06 January 2016
MEETINGS
2007 Biomedical Advanced Research and Development Authority (BARDA) Industry Day
03 August 2007